Intravesical botulinum toxin for adults with non-neurogenic bladder conditions a review of clinical effectiveness, cost-effectiveness and guidelines
This Rapid Response report aims to review the clinical and cost-effectiveness of botulinum toxin for the treatment of non-neurogenic bladder conditions. Guidelines associated with the use of botulinum toxin for patients with non-neurogenic bladder conditions will also be examined
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2018, March 2018
|
| Edition: | Version 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This Rapid Response report aims to review the clinical and cost-effectiveness of botulinum toxin for the treatment of non-neurogenic bladder conditions. Guidelines associated with the use of botulinum toxin for patients with non-neurogenic bladder conditions will also be examined |
|---|---|
| Physical Description: | 1 PDF file (32 pages) |